Cancer clinical trials in the region Auvergne-Rhône-Alpes
509 currently recruiting clinical trials
Looking for clinical trials?
Clinical trial search is a complex process, with countless criteria to consider. Our AI assistant navigates this complexity with precise, expert-level analysis of the most relevant trials based on your medical profile. Our database is fully up to date, so you see only actively recruiting sites. It's fast and easy:
- Create your account
- Copy-paste your latest medical report
- Our AI-based assistant does the rest for you
Whether you are a patient or a doctor, create an account to find and apply for the most relevant clinical trials:
Phase 2
Brain tumors / Central nervous system tumors
#NCT03970447
#2024-511452-40-00
GBM récurrent
Required histologic types
Gliomas
Required histologic sub types
Glioblastoma
Required number of previous lines of therapy
1
2
Required previous treatments
Chemotherapy
Radiotherapy
Excluded genetic anomalies
IDH1/2
Excluded previous treatments
Systemic Treatment-Naive
Bevacizumab
3 recruiting sites
Global Coalition for Adaptive Research
Phase 2
Brain tumors / Central nervous system tumors
#NCT03970447
#2024-511452-40-00
Required histologic types
Gliomas
Required histologic sub types
Glioblastoma
Required number of previous lines of therapy
None
Required previous treatments
Systemic Treatment-Naive
Excluded genetic anomalies
IDH1/2
Excluded previous treatments
Immunotherapy
Chemotherapy
Radiotherapy
Radiochemotherapy
3 recruiting sites
Global Coalition for Adaptive Research
Phase 2
Brain tumors / Central nervous system tumors
#NCT04945148
#2024-511026-31-01
Required histologic types
Gliomas
Required histologic sub types
Glioblastoma
Required number of previous lines of therapy
None
Required previous treatments
Systemic Treatment-Naive
Surgery
Excluded genetic anomalies
IDH1/2
5 recruiting sites
Hopital Foch
Phase 2
Lymphoma
#NCT05463263
Required histologic types
B cell lymphoma
T cell lymphoma
Required central nervous system lesions
None
Required number of previous lines of therapy
2
3 or more
Excluded previous treatments
Systemic Treatment-Naive
5 recruiting sites
Step Pharma, SAS
Phase 2
Brain tumors / Central nervous system tumors
#NCT02394626
Required histologic types
Gliomas
Required histologic sub types
Glioblastoma
Required number of previous lines of therapy
1
Required previous treatments
Surgery
Radiotherapy
8 recruiting sites
Insel Gruppe AG, University Hospital Bern
Phase 2
Lung cancer
#NCT03175224
#2024-514542-37-00
Required histologic types
NSCLC (Non-Small Cell Lung Cancer)
Required disease stage
Locally Advanced
Metastatic
Required genetic anomalies
EGFR
MET
Required number of previous lines of therapy for current stage of disease
None
1
Required previous treatments at advanced or metastatic stage
Targeted therapy
Excluded genetic anomalies
ALK
BRAF
KRAS G12C
KRAS non G12C
NTRK-1/2/3
RET
ROS-1
5 recruiting sites
Apollomics
Phase 2
Lung cancer
#NCT03175224
#2024-514542-37-00
Required histologic types
NSCLC (Non-Small Cell Lung Cancer)
Required disease stage
Locally Advanced
Metastatic
Required genetic anomalies
MET
Required number of previous lines of therapy for current stage of disease
None
Required previous treatments at advanced or metastatic stage
Systemic Treatment-Naive
Excluded genetic anomalies
ALK
BRAF
EGFR
KRAS G12C
KRAS non G12C
NTRK-1/2/3
RET
ROS-1
Excluded previous treatments at advanced or metastatic stage
Targeted therapy
5 recruiting sites
Apollomics
Phase 2
Lung cancer
#NCT03175224
#2024-514542-37-00
Required histologic types
NSCLC (Non-Small Cell Lung Cancer)
Required disease stage
Locally Advanced
Metastatic
Required genetic anomalies
MET
Required number of previous lines of therapy for current stage of disease
1
2
3 or more
Required previous treatments at advanced or metastatic stage
Immunotherapy
Chemotherapy
Excluded genetic anomalies
ALK
BRAF
EGFR
KRAS G12C
KRAS non G12C
NTRK-1/2/3
RET
ROS-1
Excluded previous treatments at advanced or metastatic stage
Targeted therapy
5 recruiting sites
Apollomics
Phase 2
Lung cancer
#NCT03175224
#2024-514542-37-00
Required histologic types
NSCLC (Non-Small Cell Lung Cancer)
Required disease stage
Locally Advanced
Metastatic
Required genetic anomalies
MET
Required number of previous lines of therapy for current stage of disease
1
2
3 or more
Required previous treatments at advanced or metastatic stage
Immunotherapy
Chemotherapy
Excluded genetic anomalies
ALK
BRAF
EGFR
KRAS G12C
KRAS non G12C
NTRK-1/2/3
RET
ROS-1
Excluded previous treatments at advanced or metastatic stage
Targeted therapy
5 recruiting sites
Apollomics
Phase 2
Breast cancer
Prostate cancer
Colon cancer
Rectal cancer
Kidney cancer
Pancreas cancer
Liver and bile duct cancer
Bladder / Urinary Tract / Urethral cancer
Stomach and esophageal cancer
Endometrial cancer
Ovarian / Fallopian tubes / Peritoneum cancer
Head and neck cancer
Sarcoma and GIST
Thymus cancer
Penile cancer and germ cell tumors
Cervical / Vulvar / Vaginal cancer
Small intestine and appendix cancer
Thyroid and adrenal gland cancer
#NCT03175224
#2024-514542-37-00
Cohortes C, D
Required disease stage
Locally Advanced
Metastatic
Required genetic anomalies
MET
Required number of previous lines of therapy for current stage of disease
1
2
3 or more
Excluded genetic anomalies
BRAF
EGFR
KRAS G12C
KRAS non G12C
NTRK-1/2/3
RET
ALK
ROS-1
Excluded previous treatments at advanced or metastatic stage
Systemic Treatment-Naive
Targeted therapy
5 recruiting sites
Apollomics